MGI Pharma News
Most Popular MGI Pharma Story
Eisai inks $255M deal to buy AkaRx
New Jersey-based AkaRx is getting bought out for $255 million by Japan's Eisai, which picked up the option to buy the developer when it scooped up MGI Pharma in a $3.9 billion buyout almost two years... Read more...
Latest Headlines
- December 18, 2009
- July 28, 2008
- December 10, 2007
- November 29, 2007
- August 30, 2007
- August 29, 2007
- December 13, 2006
- October 12, 2006
- August 9, 2006
- August 8, 2006
- August 8, 2006
- July 19, 2006
- July 5, 2006
- May 30, 2006
- May 2, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
